Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 52

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 52
---
 votes which are cast by those shareholders entitled to vote who are
present in person or by proxy at such general meeting. Immediately after the offering, the
two Class B shareholders, consisting of LTO Holdings Ltd. and Qingtian Holdings Ltd., will
own an aggregate of 8,500,000 ordinary shares, consisting of 7,500,000 Class A Ordinary Shares
and 1,000,000 Class B Ordinary Shares, representing 89.11% of our total voting power of our
outstanding ordinary shares. In cases where their interests are aligned and they vote together,
they could control the outcome of the matters submitted to shareholders for approval, including
the removal of any of the directors. Therefore, if the two Class B shareholders vote together
against the removal of any director, you may not be able to remove such director.

Living Homeopathy’s lack of effective internal controls over financial reporting may affect its ability to accurately report its financial results or prevent fraud, which may affect the market for and price of Living Homeopathy’s Class A Ordinary Shares.

To implement Section 404 of the Sarbanes-Oxley Act of 2002, the SEC adopted rules requiring public companies to include a report of management on the company’s internal control over financial reporting. Prior to filing the registration statement of which this prospectus is a part, Living Homeopathy was a private company with limited accounting personnel and other resources for addressing Living Homeopathy’s internal control over financial reporting. Living Homeopathy’s management has not completed an assessment of the effectiveness of Living Homeopathy’s internal control over financial reporting and its independent registered public accounting firm has not conducted an audit of Living Homeopathy’s internal control over financial reporting.

<div align='center'>27</div>

Living Homeopathy will be subject to the requirement that it maintains internal controls and that management performs periodic evaluation of the effectiveness of the internal controls. Effective internal control over financial reporting is important to prevent fraud. As a result, Living Homeopathy’s business, financial condition, results of operations and prospects, as well as the market for and trading price of the Class A Ordinary Shares, may be materially and adversely affected if Living Homeopathy does not have effective internal controls. Before this offering, Living Homeopathy was a private company with limited resources. As a result, Living Homeopathy may not discover any problems in a timely manner and current and potential shareholders could lose confidence in Living Homeopathy’s financial reporting, which would harm Living Homeopathy’s business and the trading price of Living Homeopathy’s Class